rs80097077

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_020549.5(CHAT):​c.1682G>A​(p.Arg561Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0096 in 1,614,060 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0081 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0098 ( 78 hom. )

Consequence

CHAT
NM_020549.5 missense

Scores

5
8
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 8.02

Publications

7 publications found
Variant links:
Genes affected
CHAT (HGNC:1912): (choline O-acetyltransferase) This gene encodes an enzyme which catalyzes the biosynthesis of the neurotransmitter acetylcholine. This gene product is a characteristic feature of cholinergic neurons, and changes in these neurons may explain some of the symptoms of Alzheimer's disease. Polymorphisms in this gene have been associated with Alzheimer's disease and mild cognitive impairment. Mutations in this gene are associated with congenital myasthenic syndrome associated with episodic apnea. Multiple transcript variants encoding different isoforms have been found for this gene, and some of these variants have been shown to encode more than one isoform. [provided by RefSeq, May 2010]
CHAT Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 6
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 7 uncertain in NM_020549.5
BP4
Computational evidence support a benign effect (MetaRNN=0.025550604).
BP6
Variant 10-49655142-G-A is Benign according to our data. Variant chr10-49655142-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128721.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00811 (1235/152238) while in subpopulation AMR AF = 0.0155 (237/15288). AF 95% confidence interval is 0.0139. There are 9 homozygotes in GnomAd4. There are 607 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHATNM_020549.5 linkc.1682G>A p.Arg561Gln missense_variant Exon 12 of 15 ENST00000337653.7 NP_065574.4 P28329-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHATENST00000337653.7 linkc.1682G>A p.Arg561Gln missense_variant Exon 12 of 15 1 NM_020549.5 ENSP00000337103.2 P28329-1

Frequencies

GnomAD3 genomes
AF:
0.00812
AC:
1235
AN:
152120
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00256
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0155
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000623
Gnomad FIN
AF:
0.00669
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0111
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00750
AC:
1885
AN:
251288
AF XY:
0.00751
show subpopulations
Gnomad AFR exome
AF:
0.00160
Gnomad AMR exome
AF:
0.00997
Gnomad ASJ exome
AF:
0.00992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00725
Gnomad NFE exome
AF:
0.0105
Gnomad OTH exome
AF:
0.00946
GnomAD4 exome
AF:
0.00976
AC:
14264
AN:
1461822
Hom.:
78
Cov.:
37
AF XY:
0.00947
AC XY:
6890
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.00164
AC:
55
AN:
33480
American (AMR)
AF:
0.0104
AC:
465
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00830
AC:
217
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000359
AC:
31
AN:
86256
European-Finnish (FIN)
AF:
0.00826
AC:
441
AN:
53372
Middle Eastern (MID)
AF:
0.00659
AC:
38
AN:
5768
European-Non Finnish (NFE)
AF:
0.0113
AC:
12533
AN:
1111994
Other (OTH)
AF:
0.00800
AC:
483
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
814
1628
2441
3255
4069
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00811
AC:
1235
AN:
152238
Hom.:
9
Cov.:
32
AF XY:
0.00816
AC XY:
607
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.00255
AC:
106
AN:
41544
American (AMR)
AF:
0.0155
AC:
237
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4812
European-Finnish (FIN)
AF:
0.00669
AC:
71
AN:
10614
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0111
AC:
754
AN:
68006
Other (OTH)
AF:
0.0114
AC:
24
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00984
Hom.:
23
Bravo
AF:
0.00802
TwinsUK
AF:
0.0132
AC:
49
ALSPAC
AF:
0.0130
AC:
50
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.0102
AC:
88
ExAC
AF:
0.00743
AC:
902
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0110
EpiControl
AF:
0.0127

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CHAT: BS1, BS2 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 03, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 16, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Familial infantile myasthenia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Benign
-0.055
T
BayesDel_noAF
Pathogenic
0.16
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.55
.;.;.;D;.;.
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
.;.;D;D;D;D
MetaRNN
Benign
0.026
T;T;T;T;T;T
MetaSVM
Uncertain
0.29
D
MutationAssessor
Uncertain
2.2
.;.;.;M;.;.
PhyloP100
8.0
PrimateAI
Uncertain
0.55
T
PROVEAN
Uncertain
-2.8
D;D;D;D;D;.
REVEL
Pathogenic
0.71
Sift
Benign
0.040
D;D;D;D;D;.
Sift4G
Benign
0.069
T;T;T;D;T;.
Polyphen
1.0
.;.;.;D;.;.
Vest4
0.66
MVP
0.96
MPC
0.96
ClinPred
0.0077
T
GERP RS
5.4
Varity_R
0.75
gMVP
0.78
Mutation Taster
=62/38
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80097077; hg19: chr10-50863188; COSMIC: COSV104639426; API